New chapter: Zelmic Becomes Part of CTR Group through acquisition
July 3, 2024Center for Translational Research AB (CTR) expands by acquiring Zelmic AB, the GMP-approved Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), specialized in development of topical and transdermal pharmaceutical formulations and drug delivery. The acquisition further expands CTRs portfolio, within pharmaceutical, regulatory, and clinical development to the CTR group.
Center for Translational Research AB (CTR) expands by acquiring Zelmic AB, the GMP-approved Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), specialized in development of topical and transdermal pharmaceutical formulations and drug delivery. The acquisition further expands CTRs portfolio, within pharmaceutical, regulatory, and clinical development to the CTR group.
Karin Meyer, CEO at CTR says: “The addition of Zelmic in our company group will enable us to offer a more integrated approach that will benefit our current and new customers. Zelmic share our vision regarding the importance of quality and high scientific knowledge combined with solid experiences in drug development. We already have a proven track record of excellent collaboration with the team at Zelmic, and I look forward to extending this further”.
“We are truly thrilled to join this dynamic group”, says David Sagna, CEO Zelmic AB. “By integrating our specialized expertise in topical drug development with the broader pharmaceutical, regulatory, and clinical capabilities of the CTR group, we can offer our clients even more comprehensive and innovative solutions. CTR’s responsive approach to clinical and pharmaceutical development aligns perfectly with Zelmic’s vision for continued growth, aiming to become the preferred Nordic partner for drug development. I am very optimistic about our future and see great synergistic potential in continuing our journey”.
About Center for Translational Research
Center for Translational Research AB (CTR) is a group of companies providing expert services and advice for product development in life sciences. CTR currently has eight subsidiaries supporting the pharmaceutical and medical technology industry: CTC Clinical Trial Consultants AB, Lablytica Life Science AB, RegSmart Life Science AB, Toxicology Knowledge Team Sweden AB, RegFile AB, Metasafe AB, QAlliance AB, CTC Netherlands and Zelmic AB. CTR is building a robust and sustainable translational research organization with the critical mass of experts and financial stability needed to support our national and international life science clients with improved treatments for patients. www.ctr-ab.se
See all news